Zobrazeno 21 - 30
of 63
pro vyhledávání: '"Guenter Breithardt"'
Autor:
Sergiu Scobioala, Simone Koenig, Guenter Michel, Aly El-Banayosy, Rainer Klocke, Wen Tian, Hendrik Milting, Lekbira Hasib, Gero Tenderich, Guenter Breithardt, Michael T. Kuhlmann, Sigrid Nikol, Matthias Stelljes
Publikováno v:
The FASEB Journal. 22:1021-1031
To identify proteins involved in cardiac regeneration, a proteomics approach was applied. A total of 26 proteins, which displayed aberrant expression in mouse hearts infarcted through ligation of the left anterior descending coronary artery, were ide
Autor:
Manesh R. Patel, Kenneth W. Mahaffey, Guenter Breithardt, Keith A.A. Fox, Adam D. DeVore, Christopher C. Nessel, Scott D. Berkowitz, Richard C. Becker, Werner Hacke, Daniel E. Singer, Anne S. Hellkamp, Graeme J. Hankey, Jonathan P. Piccini, Jonathan L. Halperin
Publikováno v:
DeVore, A D, Hellkamp, A S, Becker, R C, Berkowitz, S D, Breithardt, G, Hacke, W, Halperin, J L, Hankey, G J, Mahaffey, K W, Nessel, C C, Singer, D E, Fox, K A A, Patel, M R, Piccini, J P 2016, ' Hospitalizations in patients with atrial fibrillation : an analysis from ROCKET AF ', EP-Europace . https://doi.org/10.1093/europace/euv404
AIMS: The high costs associated with treatment for atrial fibrillation (AF) are primarily due to hospital care, but there are limited data to understand the reasons for and predictors of hospitalization in patients with AF.METHODS AND RESULTS: The RO
Autor:
Dominik Lautsch, Nilesh J. Samani, Guenter Breithardt, Dan Atar, Matthias Endres, Peter G. M. Mol, Hakima Hannachi, Maria Borentain, Anders Svensson, Andrew Zalewski, Paulus Kirchhof, Chantal Le Floch, Uwe Fraass, Salim Janmohamed, Jackson Neville Colin, Huseyin Naci, Martin J Landray, Jan G.P. Tijssen, Joerg Kreuzer, Tim Friede, Cathrine Thorstensen, Martin van Eickels, Victoria Vandzhura
Publikováno v:
European Heart Journal, 37(9), 747-754. Oxford University Press
European heart journal, 37(9), 747-754. Oxford University Press
European heart journal, 37(9), 747-754. Oxford University Press
Aims Cardiovascular disease is the most common cause of mortality and morbidity in the world, but the pharmaceutical industry's willingness to invest in this field has declined because of the many challenges involved with bringing new cardiovascular
Autor:
Pascale Guicheney, Josué Feingold, Heikki Swan, Silvia G. Priori, Päivi Johanna Latinen-Forsblom, Myriam Berthet, Medea Imboden, Eric Schulze-Bahr, Bernard Hainque, Carlo Napolitano, Véronique Fressart, Guenter Breithardt, Irene M. van Langen, Isabelle Denjoy, Arthur A.M. Wilde
Publikováno v:
New England journal of medicine, 355(26), 2744-2751. Massachussetts Medical Society
New England Journal of Medicine, 355(26), 2744-2751. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine, 355(26), 2744-2751. MASSACHUSETTS MEDICAL SOC
BACKGROUND: Congenital long-QT syndrome is a disorder resulting in ventricular arrhythmias and sudden death. The most common forms of the long-QT syndrome, types 1 and 2, are caused by mutations in the potassium-channel genes KCNQ1 and KCNH2, respect
Autor:
Sreekanth Vemulapalli, Anne S Hellkamp, W. Schuyler Jones, Jonathan P Piccini, Kenneth W Mahaffey, Richard C Becker, Graeme J Hankey, Scott D Berkowitz, Guenter Breithardt, Daniel E Singer, Keith A Fox, Robert M Califf, Manesh R Patel
Publikováno v:
Circulation. 130
Background: Hypertension (HTN) is a risk factor for stroke and bleeding in atrial fibrillation (AF). Yet, the association between HTN stage and stroke and bleeding risk in AF is unknown. Methods: The study population included 14,256 of the patients r
Autor:
Manesh R. Patel, Werner Hacke, Guenter Breithardt, Kenneth W. Mahaffey, Keith A.A. Fox, Jonathan P. Piccini, Sean Chen, Graeme J. Hankey, Jonathan L. Halperin, Christopher C. Nessel, Scott D. Berkowitz, Anne S. Hellkamp, Daniel E. Singer, Richard C. Becker
Publikováno v:
Journal of the American College of Cardiology. 69:446
Background: Rivaroxaban is widely used for stroke prevention in patients with atrial fibrillation, yet the safety of thrombolysis in anticoagulated patients is uncertain. Methods: We analyzed the characteristics, indications, and 30-day rates of stro
Autor:
Kenneth W. Mahaffey, Graeme J. Hankey, Jonathan L. Halperin, Benjamin A. Steinberg, Rod S. Passman, Anne S. Hellkamp, Richard C. Becker, Yuliya Lokhnygina, Christopher C. Nessel, Scott D. Berkowitz, Jonathan P. Piccini, Guenter Breithardt, Keith A.A. Fox, Manesh R. Patel, Daniel E. Singer, Robert M. Califf
Publikováno v:
ResearcherID
Antiarrhythmic drug (AAD) therapy and oral anticoagulation are mainstays of atrial fibrillation (AF) treatment. We studied the use and outcomes of AADs in patients anticoagulated for stroke prophylaxis. Patients randomized in the ROCKET AF trial (n=1
Autor:
Juergen Wellmann, Nasser M. Malyar, Holger Reinecke, Ulrich Keil, Torsten Fuerstenberg, Eva Freisinger, Guenter Breithardt
Publikováno v:
European heart journal. 35(15)
Recent guidelines on acute myocardial infarction (AMI) are based on randomized clinical trials (RCTs) and registries with selected patients, and may therefore not represent 'real-life'. This analysis shows for the first time nationwide trends in AMI
Autor:
Christian Torp-Pedersen, Lisa Naditch-Brûlé, William S. Weintraub, Peter J. Schwartz, Garrett M. Fitzmaurice, A. John Camm, Andrew C.T. Ha, Jean-Yves Le Heuzey, Harry J.G.M. Crijns, Peter R. Kowey, Eric N. Prystowsky, Guenter Breithardt, Paul Dorian
Publikováno v:
Ha, A C T, Breithardt, G, Camm, A J, Crijns, H J, Fitzmaurice, G M, Kowey, P R, Heuzey, J-Y L, Naditch-Brûlé, L, Prystowsky, E N, Schwartz, P J, Torp-Pedersen, C, Weintraub, W S & Dorian, P 2014, ' Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control : insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF) ', Circulation: Cardiovascular Quality and Outcomes, vol. 7, pp. 896-904 . https://doi.org/10.1161/HCQ.0000000000000011
Circulation : Cardiovascular Quality and Outcomes, 7(6), 896-904. LIPPINCOTT WILLIAMS & WILKINS
Circulation : Cardiovascular Quality and Outcomes, 7(6), 896-904. LIPPINCOTT WILLIAMS & WILKINS
Background— Improving health-related quality of life (HRQoL) is an important treatment goal in the management of patients with atrial fibrillation (AF). Uncertainty exists as to whether patients’ HRQoL differ when treated with medical rhythm cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d1bf84cc3007ea928e5bccdaca822dd
https://vbn.aau.dk/da/publications/5f99234d-a251-4357-a1df-fd74701821ca
https://vbn.aau.dk/da/publications/5f99234d-a251-4357-a1df-fd74701821ca
Publikováno v:
European Heart Journal. 20:1826-1832
Aims The purpose of this study was to assess the acute and long-term success of accessory pathway ablation in a single large-volume centre, concentrating on long-term recurrences and the clinical use of antiarrhythmic drugs. Methods and Results A tot